Altered brain function and its spatial correlations with neurotransmitter maps in anterior shoulder pain patients Authors: Zhijun Diao, Huan Li, Yujia Li, Chengxiang Liu, Yunsong Zheng, Jingdong Lu, Yintao Liu, Zi Wei, Peng Liu, Haifa Qiao Published: 2026 ABSTRACT AbstractNeuroimaging studies have reported that chronic pain may be associated with brain functional changes and related molecular mechanisms. However, there are few studies in anterior shoulder pain (ASP). Thus, we aimed to assess the possible brain functional changes and their associations with neurotransmitter receptor maps in ASP patients. Resting-state functional magnetic resonance imaging data were obtained from 27 ASP patients and 20 healthy controls (HCs). Regional homogeneity (ReHo) and fractional amplitude of low-frequency fluctuation (fALFF) methods were used to examine altered brain functions. JuSpace toolbox was employed for evaluating the spatial correlations between ReHo and fALFF changes and neurotransmitter receptor maps. Regression analysis was conducted to explore the associations between neuroimaging findings and clinical characteristics in ASP patients. Furthermore, we investigated reliable biomarkers to distinguish ASP patients from HCs using receiver operating characteristic (ROC) curve analysis. ASP patients had abnormal ReHo/fALFF in the middle temporal gyrus, putamen, caudate, pallidum, precentral gyrus, medial prefrontal cortex, precuneus, posterior cingulate cortex and inferior temporal gyrus. ReHo/fALFF alterations in ASP patients were associated with the serotonin, dopamine, GABA, choline, glutamate and norepinephrine neurotransmitter systems. Visual analog scale was positively correlated with ReHo in the right insula. Moreover, ROC analysis showed higher classification accuracy in the middle temporal gyrus, precentral gyrus and putamen. Our study investigated abnormal brain function and associated neurotransmitter receptor maps in ASP patients, which may contribute to improving our understanding of the pathophysiological mechanisms in ASP.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1007/s11682-026-01171-5.Keywords: Anterior shoulder pain, Regional homogeneity, Fractional amplitude of low-frequency fluctuation, Neurotransmitter, Resting-state functional magnetic resonance imaging Introduction Anterior shoulder pain (ASP) is one of the most common complaints in chronic shoulder pain characterized by pain in the front of the shoulder and limited movement (Raney et al., 2017). It is typically caused by long head of biceps tendinitis, which is an aseptic inflammation arising from repeated friction, compression and degeneration of the tendon in the bicipital groove (Kao et al., 2023). ASP seriously impacts patients’ quality of life. However, the pathophysiology of ASP remains unclear. Accumulating studies have suggested that chronic pain is associated with brain functional changes (Zhang et al., 2017; Veréb et al., 2021). Regional homogeneity (ReHo) and fractional amplitude of low-frequency fluctuations (fALFF) are common approaches for exploring alterations in brain function. ReHo has better test-retest reliability, and higher ReHo indicates greater coherence and centrality of brain regions activities (Lv et al., 2018). The fALFF is less sensitive to physiological noise and has better gray matter specificity and sensitivity in detecting spontaneous brain activity (Kim et al., 2021). Both fALFF and ReHo can provide information about the activity of whole brain regions (Lv et al., 2018). These two methods have been widely applied in chronic pain studies (Li et al. 2020a, b, c; Kim et al., 2021; Shen et al., 2022). Zhang et al. found altered ReHo in the anterior cingulate cortex, insula and cingulate cortex in chronic pain patients, and these changes were related to pain sensitivity (Zhang et al. 2024a, b). Compared to healthy controls (HCs), knee osteoarthritis patients showed abnormal fALFF in the left fusiform, which was positively correlated with pain duration and pain intensity (Guo et al., 2021). A study of chronic ankle instability discovered increased ReHo in the postcentral gyrus, precentral gyrus (PreCG) and middle frontal gyrus, as well as decreased fALFF in the orbital-frontal cortex in patients (Shen et al., 2022). However, there is limited understanding of aberrant brain function based on ReHo and fALFF methods in ASP patients. Previous studies reported that multiple neurotransmitter systems were involved in pain regulation processes in the cerebral cortex and subcortical structures (López-Avila et al., 2004; Xie et al., 2009). A study combining proton magnetic resonance spectroscopy and functional magnetic resonance imaging (fMRI) found that altered glutamate level within the insula was related to alterations in fMRI-determined blood oxygenation level–dependent (BOLD) activation caused by experimental pressure pain in fibromyalgia patients (Harris et al., 2008). Reduced gamma-aminobutyric acid (GABA) level in the medial prefrontal cortex was observed in inflammatory bowel disease patients, which correlated with changes of functional connectivity between the medial prefrontal cortex and frontal pole (Wang et al., 2023). An animal experiment indicated that BOLD activity in the striatum could be increased by optogenetic stimulation of midbrain dopamine neurons (Ferenczi et al., 2016). The recently introduced JuSpace toolbox can help reveal abnormalities in neurotransmitter maps through analyzing the spatial correlations between MRI-based determinations and derived positron emission tomography and single photon computed emission tomography maps (Dukart et al., 2021). Yet, the spatial associations between brain functional changes and specific neurotransmitter systems in ASP patients are not fully understood. In this study, we aimed to investigate altered brain function and its associations with neurotransmitter maps in ASP patients. We also examined the relationships between visual analog scale (VAS) and Constant-Murley score (CMS) and neuroimaging findings. Receiver operating characteristic (ROC) curve analysis was used to investigate reliable biomarkers to distinguish ASP patients from HCs. We hypothesized that (1) compared to HCs, the altered brain function could be found in ASP patients; (2) the neuroimaging findings might be potentially correlated with neurotransmitter maps and clinical characteristics; and (3) changed brain regions could be regarded as reliable biomarkers to distinguish ASP patients from HCs. Materials and methods Ethics statement This study was approved by the Ethics Committee of the Affiliated Hospital of Shaanxi University of Chinese Medicine, in accordance with the principles outlined in the Declaration of Helsinki. All participants voluntarily participated in the study and provided written informed consent. Participants Twenty-seven ASP patients and twenty age- and gender-matched HCs were included in the study. VAS was used to evaluate the pain intensity of patients. VAS score ranges from 0 to 10, with 0 means no pain and 10 means worst pain. CMS was used as a measure of shoulder joint function, and the score range was 0-100. A higher CMS score indicates better shoulder joint function. Detailed information on exclusion and inclusion criteria is provided in Supplementary materials. Data acquisition All functional MRI data were acquired on a Siemens Skyra 3.0T MRI (Skyra, Siemens, Germany) scanner system. Detailed information on data acquisition is provided in Supplementary materials. Data preprocessing The functional data were preprocessed with Data Processing and Analysis for Brain Imaging (DPABI, http://www.rfmri.org/dpabi) in MATLAB (MathWorks, Natick, MA, USA). Detailed information on data preprocessing is provided in Supplementary materials. ReHo analysis The data were detrended, and then band-pass filtering (0.01–0.10 Hz) was used to reduce the influence of physiological noise. Kendall’s coefficient of concordance was used to calculate the similarity between a given voxel and its 26 nearest voxels. The individual ReHo maps were calculated in a voxel-wise fashion, and then divided by the global mean ReHo maps for standardization. Finally, these ReHo maps were spatially smoothed with a Gaussian kernel of 4 mm full-width at half maximum (FWHM). fALFF analysis The images were Gaussian smoothed and removed the linear drift. The time series of a given voxel was converted into the frequency domain using a fast Fourier transform to obtain the power spectrum. The square root of the power spectrum was calculated at each frequency, and the average square root was computed across 0.01 to 0.10 Hz for each voxel. The fALFF was defined as the ratio between the sum of the amplitude within the low-frequency range and the whole frequency range. Spatial correlations with neurotransmitter maps The JuSpace toolbox (https://github.com/juryxy/JuSpace) was used to evaluate the spatial relationships between ReHo/fALFF changes and neurotransmitter receptor maps in ASP patients (Dukart et al., 2021). The following neurotransmitter systems were considered: 5-hydroxytryptamine receptor subtypes 1a, 1b, and 2a (5HT1a, 5HT1b, 5HT2a), cannabinoid 1 (CB1) receptor, dopamine D1 and D2 (D1, D2) receptors, dopamine transporter, dopamine synthesis capacity, gamma-aminobutyric acid type A receptor (GABAa), µ-opioid receptor, noradrenaline transporter, serotonin transporter, vesicular acetylcholine transporter, and metabotropic glutamate receptor type 5 (mGluR5). Statistical analysis Statistical Parameter Mapping (SPM, http://www.fil.ion.ucl.ac.uk/spm) based on MATLAB was used for statistical analysis. The differences of fALFF or ReHo between ASP patients and HCs were tested by an independent two-sample t-test (Gaussian random field [GRF] corrected, voxel P < 0.005, cluster P < 0.05). SPSS 25.0 software was used for demographic and clinical characteristics analysis. Independent two-sample t-test and Chi-square test were used to compare the demographic characteristics of the two groups. The P < 0.05 was considered statistically significant. ROC curve analysis was used to explore whether the brain regions with altered ReHo/fALFF could serve as biomarkers to distinguish ASP patients from HCs. A nonparametric permutation test was used to assess the statistical significance (5000 permutations, P < 0.05). Spearman’s correlation coefficients (Fisher’s Z transformed) were calculated between ReHo and fALFF maps and neurotransmitter receptor density maps. Exact P-values with 10,000 permutations (adjusted the spatial autocorrelation) were computed to test if the distribution of the observed Fisher’s Z-transformed correlation coefficients deviated from the null distribution. To investigate effects of clinical characteristics and minimize any unintentional bias resulting from region specific prior hypotheses, we performed a whole-brain regression analysis to reveal potential correlations between brain regions and VAS and CMS scores. The preprocessed ReHo/fALFF images were input into the multiple regression model and VAS/CMS scores were used as covariates of interest. Age and sex were input as covariates of no interest (GRF corrected, voxel P < 0.005, cluster P < 0.05). Results Clinical characteristics results These studies investigated a total of 27 ASP patients and 20 HCs. The demographic and clinical characteristics of the two groups are summarized in Table 1. No significant group differences were observed in age and sex (P > 0.05). Table 1Clinical characteristics of ASP patients and HCsASP(n = 27)HCs(n = 20)P-valueAge(years)21.22 ± 1.5322.1 ± 2.290.247aSex(male/female)17/1010/100.374bVAS5.38 ± 0.88--CMS49.16 ± 9.22--Results are expressed as mean ± standard deviation (SD)ASP Anterior shoulder pain, HCs Healthy controls, VAS Visual analog score, CMS Constant-Murley scorea The P-value was obtained by Independent two-sample t-testb The P-value was obtained by Chi-square test Clinical characteristics of ASP patients and HCs Results are expressed as mean ± standard deviation (SD) ASP Anterior shoulder pain, HCs Healthy controls, VAS Visual analog score, CMS Constant-Murley score a The P-value was obtained by Independent two-sample t-test b The P-value was obtained by Chi-square test ReHo and fALFF results Compared to HCs, ASP patients showed increased ReHo in the left middle temporal gyrus (MTG), bilateral putamen (PUT), right caudate (CAU), bilateral pallidum (PAL) and left PreCG, while decreased ReHo were found in the bilateral medial prefrontal cortex (MPFC) and bilateral precuneus (PCUN) (Fig. 1A). Meanwhile, fALFF increased in the bilateral posterior cingulate cortex (PCC), left PreCG, right PUT, right MTG and bilateral PCUN, as well as fALFF decreased in the bilateral inferior temporal gyrus (ITG) (Fig. 1B). ReHo and fALFF differences between ASP patients and HCs. A results in ReHo, B results in fALFF, ReHo regional homogeneity, fALFF fractional amplitude of low-frequency fluctuation, ASP anterior shoulder pain, HCs healthy controls, MTG middle temporal gyrus, PUT putamen, CAU caudate, PAL pallidum, PreCG precentral gyrus, MPFC medial prefrontal cortex, PCUN precuneus, PCC posterior cingulate cortex, ITG inferior temporal gyrus, R right Spatial correlation results Altered ReHo in ASP patients were significantly correlated with the spatial distribution of the D1 receptor (rho = 0.20, P < 0.001), D2 receptor (rho = 0.16, P < 0.001), dopamine transporter (rho = 0.31, P < 0.001), dopamine synthesis capacity (rho = 0.22, P < 0.001), noradrenaline transporter (rho = 0.23, P < 0.001), serotonin transporter (rho = 0.24, P < 0.001), and vesicular acetylcholine transporter (rho = 0.30, P < 0.001) maps (Fig. 2A). Altered fALFF in ASP patients were significantly associated with the 5HT1b receptor (rho = 0.16, P < 0.001), 5HT2a receptor (rho = 0.18, P < 0.001), CB1 receptor (rho = 0.18, P < 0.001), D2 receptor (rho = 0.22, P < 0.001), GABAa receptor (rho = 0.20, P < 0.001), and mGluR5 receptor (rho = 0.21, P < 0.001) maps (Fig. 2B). The spatial correlations between ReHo and fALFF and neurotransmitter maps. A results in ReHo, B results in fALFF, 5HT1a serotonin 5-hydroxytryptamine receptor subtypes 1a, 5HT1b serotonin 5-hydroxytryptamine receptor subtypes 1b, 5HT2a serotonin 5-hydroxytryptamine receptor subtypes 2a, CB1 cannabinoid 1 receptor, D1 dopamine D1, D2 dopamine D2, DAT dopamine transporter, FDOPA dopamine synthesis capacity, GABAa gamma-aminobutric acid type A receptor, MU µ-opioid receptor, N AT noradrenaline transporter, SERT serotonin transporter, VAChT vesicular acetylcholine transporter, mGLUR5 metabotropic glutamate receptor type 5. * indicates correlation values survived Bonferroni’s correction Regression analysis Within-group regressions in ASP patients showed that there was a significantly positive correlation between ReHo in the right insula and VAS scores (Fig. 3). No significant correlations were found between any brain region and CMS. Relationship between ReHo in the right insula and VAS. ReHo regional homogeneity, ASP anterior shoulder pain, HCs healthy controls, VAS visual analog score, R right ROC curve results The ROC results showed that altered ReHo/fALFF in specific regions could serve as potential biomarkers to distinguish ASP patients from the HCs (Fig. 4). The areas under the curve (AUC) for these regions were as follows: 0.819 in the left MTG and 0.869 in the left PreCG for ReHo, 0.911 in the right MTG and 0.843 in the right PUT for fALFF. All results achieved a significance level of P < 0.0001 for AUC. Receiver operating characteristic curves of the imaging assessing. A left MTG in ReHo, B left PreCG in ReHo, C right MTG in fALFF, D right PUT in fALFF, ReHo regional homogeneity, fALFF fractional amplitude of low-frequency fluctuation, MTG middle temporal gyrus, PreCG precentral gyrus, PUT putamen Discussion In this study, we investigated the brain functional alterations and their relationships with neurotransmitter receptor maps in ASP patients. Compared to HCs, ASP patients showed altered ReHo in the MTG, PUT, CAU, PAL, PreCG, MPFC and PCUN, as well as altered fALFF in the PCC, PreCG, PUT, MTG, PCUN and ITG. The MTG, PreCG and PUT exhibited better classification performance. ReHo in the right insula was positively correlated with VAS scores. Changes of ReHo/fALFF were related to spatial distribution of the serotonin, dopamine, GABA, choline, glutamate and norepinephrine neurotransmitter receptors. This study observed that ASP patients had both increased ReHo and fALFF in the MTG, PreCG and PUT compared to HCs. Increased ReHo in the MTG was observed in chronic pain patients, suggesting it was involved in pain regulation (Li et al. 2020a, b, c). The abnormal low-frequency activity in the MTG was found to be associated with neuromuscular signals, which could be a maladaptive response to movement and impaired pain modulation in chronic low back pain patients (Zhang et al. 2024a, b). The PreCG is vital for motor output and linked to pain perception and regulation (Ge et al., 2023). In patients with complex regional pain syndrome, a significant increase in activation was found in the PreCG, probably correlated with a widely premotor role (Kohler et al., 2019). The PUT is involved in production of movement and the integration of pain-related multisensory information (Kowalski et al., 2023). We found that these regions exhibited high accuracy in distinguishing ASP patients from HCs though ROC curve analysis, indicating that they could be potential biomarkers for ASP. Thereby, increased ReHo and fALFF in these regions may imply dysfunction of pain modulation and motor deficits in ASP patients. In our study, ASP patients had increased ReHo/fALFF in the basal ganglia (including the CAU, PAL and PUT) compared to HCs. The basal ganglia are widely acknowledged as key structures for motor control (Chuhma et al., 2019). The CAU mediates avoidance and nociceptive behaviors, and integrates nociceptive inputs to generate coordinated and spatially guided motor responses (Rukavina et al., 2024). The PUT is an integral component of both the dopamine and opioid receptor systems, which play a role in reward processes like analgesia (Azqueta-Gavaldon et al., 2020). Musculoskeletal pain in Parkinson’s disease was implicated in the severity of dopaminergic impairments in the basal ganglia (Rukavina et al., 2024). A study established a rat model of chronic neuropathic pain to investigate changes within the opioid system and found reduced opioid receptor availability in the caudate-putamen of rats with chronic neuropathic pain (Thompson et al., 2018), which suggested that the CAU was implicated in chronic pain. The PAL is involved in encoding expected reward and coordinating motivated behaviors, particularly in mediating the interactions between pain and pleasure (De Pauw et al., 2020; Coppieters et al., 2021). Based on these findings, our study observed changes of the basal ganglia in ASP patients may not merely affect motor responses but may also be linked to abnormal reward mechanism. Our study found altered ReHo/fALFF in the certain regions within the default mode network (DMN), including the MPFC, PCC, PCUN and ITG (Seo et al., 2017; Jones et al., 2020). It has been reported that the DMN dysfunction is a potential biomarker of pain regulation (Niu et al., 2020). The MPFC integrates pain-related sensory characteristics, affective information, and participates in mediating functional interactions between brain regions involved in pain processing (Ong et al., 2019; Im et al., 2021). Numerous studies have exhibited that the contribution of the MPFC could trigger the inhibitory regulation of pain via descending pain modulation pathway (Li et al. 2020a, b, c; Pan et al. 2023). The MPFC abnormalities in knee osteoarthritis patients suggested it played a role in the suppression of chronic pain (Hiramatsu et al., 2014). Another study showed abnormal spontaneous activity in the MPFC was related to pain intensity in chronic low back pain patients (Zhang et al. 2024a, b). Moreover, the PCC and PCUN were observed to be functionally changes in chronic pain patients, which might reflect impaired pain-related sensory function (Li et al. 2020a, b, c). The ITG is involved in attention, short-term memories and sensory information processing (Cheng et al., 2024). Cunningham et al. detected a significant negative correlation between the activity in the ITG and shoulder instability score (Cunningham et al., 2015). Taken together, we speculate that aberrant ReHo/fALFF in these regions may suggest that the dysfunctions of DMN, affecting pain-related pathway and sensory processing in ASP patients. Another noteworthy finding from our study was that there was a positive correlation between ReHo in the right insula and VAS of ASP patients. The main brain region that remains active during pain was the insula (Ong et al., 2019); it is intimately involved in pain perception and plays a leading role in subjective feelings associated with nociception (Fritz et al., 2016; Liu et al., 2022; Labrakakis, 2023). A recent study of chronic neck and shoulder pain revealed altered ReHo in the insula, suggesting functional changes associated with pain regulation and perception in the patient group (Zhang et al. 2024a, b). Functional changes in the insula correlated with subjective pain scores in chronic inflammatory arthritis patients (Mancini et al., 2024). Thus, the observed correlation between ReHo in the insula and VAS score in our study could imply enhanced pain feelings and disturbed underlying pain perception modulation ability in ASP patients. Our study found ReHo/fALFF alterations in ASP patients were significantly associated with multiple neurotransmitter receptor maps, mainly involving the serotonin, dopamine, GABA, choline, glutamate and norepinephrine neurotransmitter systems. Neurotransmitters are chemical substances that transmitted information between neurons; they regulate their various effects by binding to their receptors (Hyman, 2005). In the descending pain pathway, serotonin and norepinephrine neurotransmitter systems play a vital role in pain modulation, which might be related to pain experience (Zhou et al., 2023). One previous study found that there was significant correlations between hemodynamic changes and D2 receptor expressions during clinical ongoing pain (Vamvakas et al., 2022). GABA and glutamate neurotransmitter systems are the primary neurochemicals associated with inhibition and excitation, respectively (Bell et al., 2021). It has been reported that GABA levels were related to pain response, suggesting the important role of GABAergic system in pain sensation (Qian et al., 2023). Glutamate is essential for triggering and maintaining pain hypersensitivity (Breitinger & Breitinger, 2023). In chronic pain patients, long-term dysregulation of homeostatic could lead to glutamate alters (Archibald et al., 2020). Choline changes were discovered in patients with fibromyalgia and related to pain interference (Mawla et al., 2021). Based on these findings, our results may suggest that the associations between these neurotransmitter systems and aberrant brain functions in ASP patients could affect by patient’s pain experience. The underlying mechanism of these neurotransmitters in ASP needs to be further explored. There are several limitations in this study should be recognized. First, the current sample size is small, and a larger of participants should be included in the future studies. Second, our results only indicated potential correlations between brain functional alterations and neurotransmitter receptor maps. Further studies are required to determine what roles neurotransmitter receptors play in ASP and the timing and directionality of these changes. Moreover, neurotransmitter receptor maps were collected from an independent cohort, which could cause differences in age and sex between participants in our study and in independent cohort. More age- and sex-matched samples would be considered to further validate the potential correlations between brain functional alterations and neurotransmitter receptor maps. Finally, extensive longitudinal study is necessary. It can further explore whether these discovered alterations have changed over time and whether they are related to symptoms changes through longitudinal studies. Conclusions This study revealed that the brain functional alterations in ASP patients occurred in the MTG, PreCG, basal ganglia and DMN. The ROC analysis showed better classification ability in the MTG, PreCG and PUT, suggesting the key roles these brain regions play in discriminating ASP patients from HCs. There was a significantly positive correlation between the insula and VAS. Moreover, altered brain function in ASP patients was related to various neurotransmitter receptor maps. These findings may link to maladaptive movement responses, pain regulation impairments, and abnormal sensory processing in ASP patients. Overall, our study effectively associated neuroimaging and potential neurotransmitter receptor maps, contributing to enhancing our comprehension of the neural mechanism of ASP. Supplementary Information Supplementary Material 1. Supplementary Material 2. Supplementary Material 3. Acknowledgements The authors would like to thank all participants in this study, and express gratitude for the support of all projects. Author contributions Material preparation and data collection were performed by Zhijun Diao and Huan Li. Data analysis and writing the first draft of the manuscript were performed by Yujia Li. Chengxiang Liu contributed to the data analysis and results discussion. Jingdong Lu, Yintao Liu and Zi Wei performed data analysis. Yunsong Zheng participated in collecting and screening of data. The study conception and design, manuscript drafting, critical revision and final approval were mainly handled by Peng Liu and Haifa Qiao. All authors commented on the manuscript and approved the final manuscript. Funding This work was supported by the Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences (CI2025C005), the National Natural Science Foundation of China (82270696), the Xidian University Specially Funded Project for Interdisciplinary Exploration (TZJHF202521), the Shaanxi Provincial Key Laboratory of Integrated Acupuncture and Medication (KF2219), the Lingang Laboratory (LGLG-TKN-202205-01), the Open Fund Project of Shaanxi Key Laboratory of Acupuncture and Medicine (KF2019), and the National Key R&D Program of China (2022YFC3500701 and 2018YFC1704606). Data availability No datasets were generated or analysed during the current study. Code availability Not applicable. Declarations Ethics approval This study was approved by the Ethics Committee of the Affiliated Hospital of Shaanxi University of Chinese Medicine, in accordance with the principles outlined in the Declaration of Helsinki. Consent to participate Informed consent was obtained from all participants included in the study. Consent for publication Informed consent for publication was obtained from all participants included in the study. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Zhijun Diao and Huan Li are co-first authors and contributed equally to this work. Peng Liu and Haifa Qiao are corresponding authors and contributed equally to this work. References Associated Data Supplementary Materials Supplementary Material 1. Supplementary Material 2. Supplementary Material 3. Data Availability Statement No datasets were generated or analysed during the current study. Not applicable.